Targeted Therapies Development in the Treatment of Advanced Nonsmall Cell Lung Cancer

by Gridelli, Cesare, Felip, Enriqueta
Published 2011

EURTAC first-line phase III randomized study in advanced non-small cell lung cancer: Erlotinib works also in European population

by Gridelli, Cesare, Rossi, Antonio
Published 2012

A potential new therapeutic option for patients with advanced EGFR mutation-positive non-small cell lung cancer in first-line setting

by Gridelli, Cesare, Losanno, Tania
Published in J Thorac Dis (2016)

The reproducibility of PD-L1 scoring in lung cancer: can the pathologists do better?

by Troncone, Giancarlo, Gridelli, Cesare
Published in Transl Lung Cancer Res (2017)

“Comparison of the toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer”: is there a substantial difference or not?

by Spagnuolo, Alessia, Gridelli, Cesare
Published in J Thorac Dis (2018)

Immunotherapies in the management of epidermal growth factor receptor mutated non-small cell lung cancer: a role will be found?

by Casaluce, Francesca, Gridelli, Cesare
Published in Transl Lung Cancer Res (2018)

The combination strategies will be ready the right first-line choice for squamous lung cancer patients?

by Gridelli, Cesare, Casaluce, Francesca
Published in Transl Lung Cancer Res (2018)

Elderly patients and PD-L1-positive advanced non-small cell lung cancer: is pembrolizumab monotherapy effective and safe?

by Gridelli, Cesare, Sgambato, Assunta
Published in Ann Transl Med (2019)

The adjuvant regimen for resected EGFR mutated patients: the “same-for-all-therapy” or not?

by Gridelli, Cesare, Casaluce, Francesca
Published in Ann Transl Med (2020)

Narrative review of lung cancer treatment at the time of COVID-19 pandemia: pitfall and issues

by Casaluce, Francesca, Gridelli, Cesare
Published in Transl Lung Cancer Res (2021)

Management of lung cancer in older people

by Gridelli, Cesare., Audisio, Riccardo A.
Published 2013

The New Immunotherapy Combinations in the Treatment of Advanced Non-Small Cell Lung Cancer: Reality and Perspectives

by Rocco, Danilo, Gravara, Luigi D., Gridelli, Cesare
Published in Curr Clin Pharmacol (2020)

Lung cancer resection in octogenarian patients

by Spaggiari, Lorenzo, Petrella, Francesco, Maione, Paolo, Gridelli, Cesare
Published in J Thorac Dis (2018)

Targeting Immunometabolism Mediated by CD73 Pathway in EGFR-Mutated Non-small Cell Lung Cancer: A New Hope for Overcoming Immune Resistance

by Passarelli, Anna, Aieta, Michele, Sgambato, Alessandro, Gridelli, Cesare
Published in Front Immunol (2020)

Molecular and Genomic Profiling of Lung Cancer in the Era of Precision Medicine: A Position Paper from the Italian Association of Thoracic Oncology (AIOT)

by Normanno, Nicola, Barberis, Massimo, De Marinis, Filippo, Gridelli, Cesare
Published in Cancers (Basel) (2020)

Treatment of limited-stage small cell lung cancer in the elderly, chemotherapy vs. sequential chemoradiotherapy vs. concurrent chemoradiotherapy: that’s the question

by Gridelli, Cesare, Casaluce, Francesca, Sgambato, Assunta, Monaco, Fabio, Guida, Cesare
Published in Transl Lung Cancer Res (2016)

The role of pembrolizumab in the treatment of advanced non-small cell lung cancer

by Santabarbara, Giuseppe, Maione, Paolo, Rossi, Antonio, Palazzolo, Giovanni, Gridelli, Cesare
Published in Ann Transl Med (2016)

J-ALEX trial will crown alectinib as the standard choice for anaplastic lymphoma kinase positive untreated non-small cell lung cancer patients?

by Gridelli, Cesare, Casaluce, Francesca, Sgambato, Assunta, Palazzolo, Giovanni, Maione, Paolo
Published in J Thorac Dis (2018)

Lung cancer, elderly and immune checkpoint inhibitors

by Casaluce, Francesca, Sgambato, Assunta, Maione, Paolo, Spagnuolo, Alessia, Gridelli, Cesare
Published in J Thorac Dis (2018)

The optional approach of oncogene-addicted non-small cell lung cancer with brain metastases in the new generation targeted therapies era

by Spagnuolo, Alessia, Muto, Matteo, Monaco, Fabio, Colantuoni, Giuseppe, Gridelli, Cesare
Published in Transl Lung Cancer Res (2019)